This inventor holds 1 USPTO granted patent and 2 published patent applications and 1 EPO patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2022.
Company Filing History:
Years Active: 2022
Title: Douglas A. Levine: Innovator in Ovarian Cancer Research
Introduction
Douglas A. Levine is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer research. His work primarily focuses on ovarian cancers, particularly those associated with reduced SMARCA4 gene expression or protein function. With a commitment to advancing medical science, Levine has developed innovative methods for diagnosing and treating these challenging cancers.
Latest Patents
Levine holds a patent for "Compositions and methods for the diagnosis and treatment of ovarian cancers that are associated with reduced SMARCA4 gene expression or protein function." This patent outlines compositions and methods for identifying and treating ovarian cancers, such as small cell ovarian cancers, specifically small cell carcinoma of the ovary, hypercalcemic type (SCCOHT). These cancers are characterized by reduced SMARCA4 gene expression and/or protein function, making them sensitive to growth and/or survival inhibition by compounds that restore SMARCA4 gene expression and/or protein function. He has 1 patent to his name.
Career Highlights
Levine is affiliated with the Memorial Sloan Kettering Cancer Center, where he continues to push the boundaries of cancer research. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from ovarian cancers.
Collaborations
Levine collaborates with esteemed colleagues, including Robert Soslow and Petar Jelinic, to further enhance the impact of his research. Their combined expertise contributes to the advancement of innovative solutions in cancer treatment.
Conclusion
Douglas A. Levine stands out as a dedicated inventor in the realm of ovarian cancer research. His innovative approaches and collaborative efforts are paving the way for new diagnostic and treatment methods that could significantly benefit patients.